Anthem Blue Cross and Blue Shield has selected Community Health Network to be the “exclusive provider” for a new kind of health insurance plan—a sharp departure from Anthem’s typical strategy of offering the broadest network of hospitals and doctors.
The Indianapolis-based health insurer saw its stock tumble as much as 4.8 percent Wednesday morning after it unexpectedly named career hospital executive Joe Swedish to be its next CEO.
Joe Swedish, the CEO of Michigan-based Trinity Health since December 2004, will replace Angela Braly, who was forced out by angry investors in August. Swedish, 61, will take office on March 25.
Joe Swedish, CEO of Michigan-based Trinity Health since December 2004, will replace Angela Braly, who was forced out in August.
Don Kelso is executive director of the Indiana Rural Health Association. The trade group is trying to help its members navigate the changes coming from health care reform and the financial pressures being created by federal budget cuts. The association recently launched a service for its members called SuiteStats, which is data-management software to help hospital executives identify areas ripe for cost-cutting.
Up until now, Gov. Mike Pence and his fellow Republicans in the Legislature have been playing a game of poker with the Obama administration over a potential expansion of Indiana’s Medicaid program. But all of a sudden, Indiana’s hand just got quite a bit weaker.
To understand why Indiana’s life sciences entrepreneurs are frustrated with the flow of venture capital, look no further than this statistic from a recent PricewaterhouseCoopers report: 2012 was the slowest year for first-time life sciences investment since 1995.
Across the four largest hospital systems in central Indiana, six physicians received more than $1 million in compensation in 2011 while two others received more than $900,000 and nine others received $700,000 or more, according to the hospitals’ most recent reports to the IRS.
Purdue University announced Tuesday that some of its researchers won a five-year, $14.5 million grant from the National Science Foundation to expand the school’s online gateway for instruction, research and simulations in nanotechnology.
With Eli Lilly and Co. set to see patents expire on its best-selling drug at year’s end, it is in the company’s interest to say its pipeline is about to produce new drugs. But the Indianapolis drugmaker may be in a position to submit five new drugs for regulatory approval this year.
In the era of health care reform, hospitals will face two new challenges: They will need to run higher-volume, lower-margin businesses, and they’ll be on the hook financially for what patients do even when they’re not receiving health care. Community Health Network’s new partnership with Walgreens’ Take Care Clinics is designed to help address both issues.
Frustrated by up-and-down state funding for startup life sciences companies, industry leaders are talking up a plan to create a dedicated funding stream that could total $30 million a year.
Earnings rose 7.6 percent during the fourth quarter at Indianapolis-based Dow AgroSciences LLC as overall sales shot up 17 percent.
The Warsaw-based maker of orthopedic implants posted flat revenue and modest profit growth in 2012, but it expects revenues to grow this year by 2.5 percent to 4.5 percent.
Price increases and sales gains helped Eli Lilly and Co. offset declining revenue from its former blockbuster Zyprexa in the fourth quarter, allowing the company to beat analysts' expectations and raise its 2013 profit forecast.
Shares of Zimmer Holdings Inc. have generated impressive returns of 23 percent in the past year and some 2013 product launches could juice those results even further. But the Warsaw-based maker of orthopedic implants is also the most-exposed company in its industry to two key elements of health care reform: the medical device tax and bundled payments.
Marian University’s College of Osteopathic Medicine—only the second medical school in Indiana—will enroll 162 students this fall, about 8 percent more than it planned.
Two years ago, executives at AIT Laboratories “took their eye off the ball,” and watched the company’s business plummet 29 percent in value. Now, after two years of turmoil, the drug-testing lab says it’s poised to return to the double-digit rates of growth that made it a local star.
For a guy whose company’s stock price has lost 75 percent of its value, Kevin Modany, the CEO of ITT Educational Services Inc., sounds pretty upbeat. And it seemed to rub off on investors Thursday.
ITT Educational Services Inc. shares swooned Thursday morning after the private educator reported sinking revenue and a $9.5 million loss in the fourth quarter. But the stock rebounded strongly later Thursday.
